Skip to search formSkip to main contentSkip to account menu

tumor necrosis factor therapy

Known as: therapy, TNF, therapy, tumor necrosis factor, tnf therapy 
A biological therapy that involves the use of anti-tumor necrosis factor antagonists. It results in the inhibition of tumor necrosis factor and the… 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Immunotherapy
cytokine therapy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Predictors of Switching Anti-Tumor Necrosis Factor Therapy in Patients with Ankylosing Spondylitis
The aim of this study was to investigate the potential predictors of switching tumor necrosis factor (TNF)-α inhibitors in Korean… 
2015
2015
A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol
The aim of the Patient/Physician Reported Efficacy Determination In Clinical Practice Trial (PREDICT; ClinicalTrials identifier… 
Review
2013
Review
2013
Risk of nocardial infections with anti-tumor necrosis factor therapy.
Anti-tumor necrosis factor (anti-TNF) therapy is beneficial in the management of many chronic immune-mediated inflammatory… 
2012
2012
Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of north america cohort of rheumatoid arthritis patients
To determine whether men with rheumatoid arthritis (RA) are more likely to achieve remission compared to women. 
2011
2011
Regression of endometrial autografts in a rat model of endometriosis treated with etanercept.
Review
2010
Review
2010
Review: Anti-tumor necrosis factor therapy and influenza: keeping it in perspective
The association of opportunistic infections in the context of anti-tumor necrosis factor (TNF) antibody therapies have attracted… 
Highly Cited
2008
Highly Cited
2008
Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis.
OBJECTIVE Some patients with chronic inflammatory diseases such as rheumatoid arthritis (RA) improve rapidly from anti-tumor… 
Review
2008
Review
2008
Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
BACKGROUND Infliximab and etanercept have been included in the Israeli national list of health services since 2002 for rheumatoid… 
2005
2005
Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapy.
OBJECTIVE Androgens such as dehydroepiandrosterone sulfate (DHEAS) and testosterone are markedly lower in postmenopausal women… 
2005
2005
Retrospective study of the costs of care during the first year of therapy with etanercept or infliximab among patients aged > or =65 years with rheumatoid arthritis.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)